Cervical Dystonia Patient Registry for the Observation of Botulinum Toxin Type A Efficacy.

Trial Profile

Cervical Dystonia Patient Registry for the Observation of Botulinum Toxin Type A Efficacy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Torticollis
  • Focus Therapeutic Use
  • Acronyms CD-PROBE
  • Sponsors Allergan
  • Most Recent Events

    • 08 Jun 2017 Results (n=479) presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
    • 28 Apr 2017 Results (n=479) presented at the 69th Annual Meeting of the American Academy of Neurology.
    • 20 Apr 2017 According to an Allergan media release, data from this study will be presented at the upcoming 69th American Academy of Neurology (AAN) annual meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top